MAGNEVIST

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Lithuania, Poland, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug MAGNEVIST contains one active pharmaceutical ingredient (API):

1 Gadopentetate dimeglumine UNII K2I13DR72L - GADOPENTETIC ACID

Gadopentetic acid is a paramagnetic contrast agent for magnetic resonance imaging. Read about Gadopentetate dimeglumine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MAGNEVIST Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08CA01	Gadopentetic acid	V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 01989987
Country: EE	Ravimiamet	Identifier(s): 1018392, 1079467, 1079478, 1079489, 1079490, 1079502, 1084003, 1084014, 1624249
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 90571
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007951, 1010499, 1010500, 1010501, 1031767
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100195615
Country: SG	Health Sciences Authority	Identifier(s): 04323P
Country: US	FDA, National Drug Code	Identifier(s): 50419-188
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/28/0639, 28/28/0640, 28/28/0641, 36/28/0026, 36/28/0027, W/28/199